A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients

✍ Scribed by Davies, Janine M.; Dhruva, Nirav S.; Walko, Christine M.; Socinski, Mark A.; Bernard, Stephen; Hayes, D. Neil; Kim, William Y.; Ivanova, Anastasia; Keller, Kimberly; Hilbun, Layla R.; Chiu, Michael; Dees, E. Claire; Stinchcombe, Thomas E.

• Book ID: 119320409
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 138 KB
• Volume: 71
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2010.05.022